Goodbody Health Partners with Datar to Offer Innovative Cancer Screening
Goodbody Health Limited has partnered with Datar Cancer Genetics to introduce the Trucheck multi-cancer screening solution in the UK. This liquid biopsy technology utilizes Circulating Tumor Cells (CTCs) for early cancer detection, supported by over 40,000 individuals. The partnership aims to enhance participation in cancer screening, ultimately promoting preventative healthcare. Executive Director Dr. Vineet Datta emphasized that early detection through screening can significantly improve treatment outcomes. CEO George Thomas expressed excitement about this innovation and its integration into Goodbody's health offerings.
- Partnership with Datar Cancer Genetics enhances Goodbody's service portfolio.
- Trucheck offers innovative early cancer detection using CTC technology.
- The solution is backed by validation from over 40,000 individuals, indicating reliability.
- None.
ST PETER PORT, GUERNSEY / ACCESSWIRE / January 26, 2023 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), is pleased to announce that it has partnered with Datar Cancer Genetics ("Datar") a world-leading liquid biopsy company to offer its innovative Circulating Tumor Cell (CTC) based multi-cancer screening solution Trucheck in the UK.
According to Dr Vineet Datta, Executive Director at Datar Cancer Genetics, "There is clear evidence that cancer screening led early detection saves lives and leads to a less radical treatment with fewer side effects. Analysis of CTCs using our advanced technology through this innovative platform allows highly sensitive detection of cancer at early stages. Trucheck is a CE certified cancer screening solution offered for single and multi-organ cancer screening. We believe the solution will encourage more men and women to participate in cancer screening for a safer future. Working with Goodbody brings this screening service one-step closer to the general public."
George Thomas, Chief Executive Officer, said: "Trucheck offers a paradigm shift in cancer screening through a novel process of utilising CTCs to identify cancers in both early and advanced stages, with validation from more than 40,000 individuals. We are excited to work with Datar and to add the Trucheck cancer screening solution to our portfolio of health and wellness tests offered through our clinic network to ensure our customers get the best opportunity to take preventative measures to look after their health, at a convenient and accessible location".
Geremy Thomas, Executive Chairman, said: "We are very pleased to develop the business further under the guidance of George who has successfully led the clinic business for over two years.".
The directors of the Company accept responsibility for the contents of this announcement
The Financial Statements and Management Discussion and Analysis and further information regarding the Company can be found under the Company's profile on www.sedar.com. All press releases, financial information and other publicly reported information is published on the company website at https://goodbodyhealth.com. If you want push notifications to know when anything is published or to receive other relevant information in future please register here https://goodbodyhealth.com/news-items/
On behalf of the Board of Directors,
Contact Information:
George Thomas | Anne Tew |
Cautionary Statement Regarding Forward-Looking Statements
Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release. This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Goodbody Health's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" "plan is" or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur", "will be achieved" or "shortly". The forward-looking information and forward-looking statements contained herein include but are not limited to: the solution will encourage more men and women to participate in cancer screening for a safer future, working with Goodbody brings this screening service one-step closer to the general public and it will ensure our customers get the best opportunity to take preventative measures to look after their health, at a convenient and accessible location.
Although Goodbody Health believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements.
Goodbody Health does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.
SOURCE: Goodbody Health Limited
View source version on accesswire.com:
https://www.accesswire.com/736806/Goodbody-Health-Partners-with-Datar-to-Offer-Innovative-Cancer-Screening
FAQ
What is the partnership between Goodbody Health and Datar Cancer Genetics about?
What does the Trucheck cancer screening solution do?
When was the announcement of Goodbody Health's partnership with Datar made?
How does Trucheck improve cancer screening?
What are the expected benefits of the Trucheck solution from Goodbody Health?
